Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state
British Journal of Haematology · 2024-09 · 205 (3) · 1197-1201
DOI: 10.1111/bjh.19633 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Haematology, online erschienen am 09.07.2024. Verfasst von Amrit S Gonugunta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Department of Hematology/Oncology, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
ORCID-Profile: Muhammad Bilal Abid
Zitieren
APA
Gonugunta, A. S., Mohlere, V., & Abid, M. B. (2024). Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state. British Journal of Haematology, 205(3), 1197-1201. https://doi.org/10.1111/bjh.19633
Vancouver
Gonugunta AS, Mohlere V, Abid MB. Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state. British Journal of Haematology. 2024;205(3):1197-1201. doi:10.1111/bjh.19633
BibTeX
@article{Gonugunta2024,
author = {Gonugunta, Amrit S and Mohlere, Virginia and Abid, Muhammad Bilal},
title = {Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state},
journal = {British Journal of Haematology},
year = {2024},
volume = {205},
number = {3},
pages = {1197--1201},
doi = {10.1111/bjh.19633}
}
EUVIMED